Molbio Diagnostics invests $30 million in OptraSCAN, Health News, ET HealthWorld
Nagve: Molbio Diagnostics announced its investment of $30 million in OptraSCAN. The strategic partnership enables OptraSCAN to accelerate the development and accessibility of digital pathology solutions powered by artificial intelligence (AI). These solutions, which include cloud-based systems for slide scanning, image analysis, and secure data storage, aim to facilitate faster, more accurate diagnoses.
Sriram Natarajan, CEO, Molbio Diagnostics, said, “This strategic alliance with OptraSCAN represents a significant step in our mission to make high-quality, affordable healthcare accessible to all by bringing innovative digital pathology solutions in India and beyond, empowering clinicians with the technology needed to enhance patient care.”
OptraSCAN’s solutions are designed for various healthcare environments, from small laboratories to large medical facilities. With this partnership, OptraSCAN can expand its product portfolio and increase availability, making life-saving diagnostic technology accessible to facilities in rural and under-resourced regions in India.
Abhi Gholap, Founder and CEO, OptraSCAN, said, “This partnership will allow us to bring life-saving digital pathology solutions to a wider market, helping laboratories of all sizes make timely, precise diagnoses possible. Together with Molbio, we aim to bridge gaps in healthcare by delivering technology that supports high-quality, affordable diagnostics globally.”
In addition to improved access to diagnostic tools, this collaboration will support AI-driven pathology solutions that aim to empower healthcare professionals to diagnose diseases more efficiently, leading to better patient outcomes. The strategic investment will further OptraSCAN’s research and development, strengthen its global presence, and bring quality diagnostics to regions historically lacking access to advanced healthcare technology.
